Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Dose-Response and Substitution Analyzes of Sweet Beverage Consumption and Body Weight in Dutch Adults: The Lifelines Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Effect of Meal Texture on Postprandial Glucose Excursions and Gut Hormones After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Editorial: FIN Special Issue on PREVIEW

    Research output: Contribution to journalEditorialpeer-review

  4. What Is the Profile of Overweight Individuals Who Are Unsuccessful Responders to a Low-Energy Diet? A PREVIEW Sub-study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Erythritol and xylitol differentially impact brain networks involved in appetite regulation in healthy volunteers

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Parasympathetic tonus in type 2 diabetes and pre-diabetes and its clinical implications

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Udfordringer for perioperativ glykæmisk kontrol hos patienter med diabetes

    Research output: Contribution to journalReviewpeer-review

View graph of relations

Background: Carbohydrate restriction may benefit β-cell function and glucose metabolism in type 2 diabetes (T2D) but also leads to weight loss which in itself is beneficial. Methods: In order to determine the additional effect of carbohydrate restriction in addition to a fixed body weight loss, we randomly assigned 72 adults with T2D and obesity (mean ± SD HbA 1c 7.4 ± 0.7%, BMI 33 ± 5 kg/m 2) to a carbohydrate-reduced high-protein diet (CRHP; energy percent from carbohydrate/protein/fat: 30/30/40) or an isocaloric conventional diabetes diet (CD; 50/17/33) for 6 weeks. All foods were provided free of charge and total energy intake was tailored individually, so both groups lost 6% of baseline body weight. Results: Despite significantly greater reductions in HbA 1c (mean [95% CI] −1.9 [−3.5, −0.3] mmol/mol) after 6 weeks, the CRHP diet neither improved glucose tolerance, β-cell response to glucose, insulin sensitivity, during a 4-h oral glucose tolerance test, nor basal proinsulin secretion when compared to the CD diet, but increased C-peptide concentration and insulin secretion rate (area under the curve [AUC] and peak) significantly more (~10%, P ≤ 0.03 for all). Furthermore, compared with the CD diet, the CRHP diet borderline increased basal glucagon concentration (16 [−0.1, 34]%, P = 0.05), but decreased glucagon net AUC (−2.0 [−3.4, −0.6] mmol/L ×240 min, P < 0.01), decreased basal triglyceride and total AUC (~20%, P < 0.01 for both), and increased gastric inhibitory polypeptide total AUC (14%, P = 0.01). Conclusion: A moderately carbohydrate-restricted diet for 6 weeks decreased HbA 1c but did not improve β-cell function or glucose tolerance beyond the effects of weight loss when compared with a conventional diabetes diet in people with T2D. Clinical trials registration: www.Clinicaltrials.gov, Identifier: NCT02472951.

Original languageEnglish
Article number933118
JournalFrontiers in nutrition
Volume9
ISSN2296-861X
DOIs
Publication statusPublished - 19 Aug 2022

Bibliographical note

Copyright © 2022 Thomsen, Skytte, Samkani, Astrup, Fenger, Frystyk, Hartmann, Holst, Larsen, Madsbad, Magkos, Rehfeld, Haugaard and Krarup.

    Research areas

  • carbohydrate restriction, insulin sensitivity, low-grade inflammation, type 2 diabetes, weight loss, β-cell function

ID: 84474294